"Visit Bon Secours Mary Immaculate Hospital in Newport News, Virginia. Bon Secours Mary Immaculate Hospital is one of the many Hospitals & Medical Centers locations at Bon Secours providing good help to those in need."

During the past decade, Mary Immaculate Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 14 clinical trials were completed, i.e. on average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Immaculate Hospital" #1 sponsor was "Conatus Pharmaceuticals Inc." with 4 trials, followed by "Gilead Sciences" with 4 trials sponsored, "CymaBay Therapeutics, Inc." with 2 trials sponsored, "GOG Foundation" with 2 trials sponsored and "National Cancer Institute (NCI)" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Immaculate Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator, "Dr. Naga Chalasani, MD, Indiana University" with 1 trials as a collaborator, "Dr. Stephen A. Harrison, MD, Brooke Army Medical Center" with 1 trials as a collaborator, "Gynecologic Oncology Group" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Mary Immaculate Hospital" are "Hepatic Cirrhosis" (3 trials), "Liver Cirrhosis" (3 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (2 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (2 trials) and "Fallopian Tube Mucinous Adenocarcinoma" (2 trials). Many other conditions were trialed in "Mary Immaculate Hospital" in a lesser frequency.

Most popular intervention types in "Mary Immaculate Hospital" are "Drug" (16 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "IDN-6556" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Paclitaxel" (3 trials) and "Quality-of-Life Assessment" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mary Immaculate Hospital" are 15 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Mary Immaculate Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Mary Immaculate Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Mary Immaculate Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".